Patent search ap:("ORYZON GENOMICS S.A.") AND inv:"Carlos BUESA ARJOL" Page 1

1.

发明申请
SELECTIVE LSD1 AND DUAL LSD1/MAO-B INHIBITORS FOR MODULATING DISEASES ASSOCIATED WITH ALTERATIONS IN PROTEIN CONFORMATION 审中-公开
Title translation: 选择性LSD1和双LSD1 / MAO-B抑制剂调节与蛋白质配合变化相关的疾病

公开(公告)号：US20160081947A1

公开(公告)日：2016-03-24

申请号：US14675990

申请日：2015-04-01

Applicant: ORYZON GENOMICS S.A.

Inventor： Tamara MAES , Carlos BUESA ARJOL

IPC: A61K31/135 , A61K31/495 , A61K31/165

CPC classification number: A61K31/135 , A61K31/00 , A61K31/13 , A61K31/165 , A61K31/495 , C07C237/20 , C07D295/14

Abstract: The invention relates to methods and compositions for the treatment or prevention of protein conformation disorders. In particular, the invention relates to an LSD1 inhibitor for use in treating or preventing a protein conformation disorder, such as, e.g., Huntington Disease.

Abstract translation: 本发明涉及用于治疗或预防蛋白质构象障碍的方法和组合物。特别地，本发明涉及用于治疗或预防蛋白质构象障碍（例如亨廷顿病）的LSD1抑制剂。

Patent Agency Ranking